Skip to main content

Accelerant IPO beats expectations with $724m raise

US dollar symbol and tech_concept

Accelerant, a major player in the UK managing general agents market, has raised $723.7m (£533.9m) in an IPO in the US, with shares selling for $21, above the expected range of $18–$20.

At the end of June, the risk exchange platform and capacity provider unveiled plans to list on the New York Stock Exchange.

RelatedMGA backer Accelerant files for IPO in US Accelerant IPO could hit $578.9m Accelerant boss Radke on 30% MGA growth and enabling brokers to ‘monetise every opportunity’ Mission notches up 25th MGA partner with Carrow launch 

In mid-July, it revealed there would be 20,276,280 common shares offered by Accelerant and 8,671,088 common shares to be sold by some of its

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@insuranceage.co.uk or view our subscription options here: https://subscriptions.insuranceage.co.uk/subscribe

You are currently unable to copy this content. Please contact info@insuranceage.co.uk to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Insurance Age? View our subscription options

GI AR numbers fall again

The general insurance and protection sector saw the biggest fall in the number of appointed representatives last financial year, the Financial Conduct Authority has calculated.

Liberty opens new proposition for retail sector

Liberty Specialty Markets has launched a bespoke proposition for mid to upper-midsized retail companies, flagging it is available via dedicated hubs in Manchester, Bristol and Dublin, supported by its London head office.

Most read articles loading...

You need to sign in to use this feature. If you don’t have an Insurance Age account, please register now.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an indvidual account here: